These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16981694)

  • 1. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.
    Qasim MA; Van Etten RL; Yeh T; Saunders C; Ganz PJ; Qasim S; Wang L; Laskowski M
    Biochemistry; 2006 Sep; 45(38):11342-8. PubMed ID: 16981694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into the non-additivity effects in the sequence-to-reactivity algorithm for serine peptidases and their inhibitors.
    Lee TW; Qasim MA; Laskowski M; James MN
    J Mol Biol; 2007 Mar; 367(2):527-46. PubMed ID: 17266986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
    Bateman KS; Huang K; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
    J Mol Biol; 2001 Jan; 305(4):839-49. PubMed ID: 11162096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases.
    Qasim MA; Ganz PJ; Saunders CW; Bateman KS; James MN; Laskowski M
    Biochemistry; 1997 Feb; 36(7):1598-607. PubMed ID: 9048543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of amino acid side-chains to S1 cavities of serine proteinases.
    Lu W; Apostol I; Qasim MA; Warne N; Wynn R; Zhang WL; Anderson S; Chiang YW; Ogin E; Rothberg I; Ryan K; Laskowski M
    J Mol Biol; 1997 Feb; 266(2):441-61. PubMed ID: 9047374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
    Huang K; Lu W; Anderson S; Laskowski M; James MN
    Protein Sci; 1995 Oct; 4(10):1985-97. PubMed ID: 8535235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics.
    Song J; Laskowski M; Qasim MA; Markley JL
    Biochemistry; 2003 Jun; 42(21):6380-91. PubMed ID: 12767219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing intermolecular main chain hydrogen bonding in serine proteinase-protein inhibitor complexes: chemical synthesis of backbone-engineered turkey ovomucoid third domain.
    Lu W; Qasim MA; Laskowski M; Kent SB
    Biochemistry; 1997 Jan; 36(4):673-9. PubMed ID: 9020764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational analysis of the binding of P1 variants of domain 3 of turkey ovomucoid inhibitor to Streptomyces griseus protease B.
    Fujinaga M; Huang K; Bateman KS; James MN
    J Mol Biol; 1998 Dec; 284(5):1683-94. PubMed ID: 9878379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein inhibitors of serine proteinases: role of backbone structure and dynamics in controlling the hydrolysis constant.
    Song J; Markley JL
    Biochemistry; 2003 May; 42(18):5186-94. PubMed ID: 12731859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deleterious effects of beta-branched residues in the S1 specificity pocket of Streptomyces griseus proteinase B (SGPB): crystal structures of the turkey ovomucoid third domain variants Ile18I, Val18I, Thr18I, and Ser18I in complex with SGPB.
    Bateman KS; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
    Protein Sci; 2000 Jan; 9(1):83-94. PubMed ID: 10739250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additivity-based design of the strongest possible turkey ovomucoid third domain inhibitors for porcine pancreatic elastase (PPE) and Streptomyces griseus protease B (SGPB).
    Qasim MA; Wang L; Qasim S; Lu S; Lu W; Wynn R; Yi ZP; Laskowski M
    FEBS Lett; 2013 Sep; 587(18):3021-6. PubMed ID: 23892073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of eglin-c binding to thermitase: three-dimensional structure comparison of native thermitase and thermitase eglin-c complexes.
    Gros P; Teplyakov AV; Hol WG
    Proteins; 1992 Jan; 12(1):63-74. PubMed ID: 1553381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting proteinase specificities from free energy calculations.
    Mekonnen SM; Olufsen M; Smalås AO; Brandsdal BO
    J Mol Graph Model; 2006 Oct; 25(2):176-85. PubMed ID: 16386933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of reactive-site hydrolyzed turkey ovomucoid third domain by nuclear magnetic resonance and distance geometry methods.
    Walkenhorst WF; Krezel AM; Rhyu GI; Markley JL
    J Mol Biol; 1994 Sep; 242(3):215-30. PubMed ID: 8089843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional study of an Anemonia elastase inhibitor, a "nonclassical" Kazal-type inhibitor from Anemonia sulcata.
    Hemmi H; Kumazaki T; Yoshizawa-Kumagaye K; Nishiuchi Y; Yoshida T; Ohkubo T; Kobayashi Y
    Biochemistry; 2005 Jul; 44(28):9626-36. PubMed ID: 16008348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases.
    Krowarsch D; Dadlez M; Buczek O; Krokoszynska I; Smalas AO; Otlewski J
    J Mol Biol; 1999 May; 289(1):175-86. PubMed ID: 10339415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage display selection of P1 mutants of BPTI directed against five different serine proteinases.
    Kiczak L; Koscielska K; Otlewski J; Czerwinski M; Dadlez M
    Biol Chem; 1999 Jan; 380(1):101-5. PubMed ID: 10064144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.